SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-059166
Filing Date
2011-03-08
Accepted
2011-03-08 15:47:36
Documents
6
Period of Report
2011-03-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 19139
2 UNDERWRITING AGREEMENT dex11.htm EX-1.1 100302
3 OPINION OF AKERMAN SENTERFITT dex51.htm EX-5.1 8224
4 PRESS RELEASE dex991.htm EX-99.1 8615
5 GRAPHIC g158684g29r57.jpg GRAPHIC 4279
6 GRAPHIC g158684logo.jpg GRAPHIC 1616
  Complete submission text file 0001193125-11-059166.txt   145971
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1370 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1370 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 11671920
SIC: 2834 Pharmaceutical Preparations